Results 161 to 170 of about 6,944 (246)

Evaluating Suicidal Risk in GLP-1RA Therapy: An Umbrella Review of Meta-Analytic Evidence. [PDF]

Healthcare (Basel)
Ștefănescu C, Bratu EA, Pelin AM, Boroi D, Crecan-Suciu BD, Ștefănescu V.   +5 more
europepmc   +1 more source

Sex differences in trial representation and the cardiovascular effectiveness of newer glucose‐lowering agents in patients with and without type 2 diabetes: A systematic review and meta‐analysis of cardiovascular outcome trials

Diabetes, Obesity and Metabolism, Volume 28, Issue 3, Page 2183-2202, March 2026.
Abstract Aims The extent to which the cardiovascular benefits of sodium–glucose co‐transporter 2 inhibitors (SGLT‐2is) and glucagon‐like peptide 1 receptor agonists (GLP‐1RAs) differ by sex remains unclear. This systematic meta‐analysis aimed to investigate sex differences in trial representation and the cardiovascular and kidney efficacy of SGLT‐2is ...
Magdaline Zawadka, Erwin Taguiam, Mê‐Linh Lê, Rohan Sanjanwala, Shuangbo Liu, Ashish H. Shah, Setor K. Kunutsor   +6 more
wiley   +1 more source

SAT-416 The impact of SGLT-2i and GLP-1RA on liver-related events in patients with metabolic dysfunction-associated steatotic liver disease: a systematic review and network meta-analysis

Lu Li, Ka Shing Cheung, Xianhua Mao, Lung‐Yi Mak, Rex Wan‐Hin Hui, Man‐Fung Yuen, Wai‐Kay Seto   +6 more
openalex   +1 more source

Construction of a prognostic assessment model for diabetic nephropathy based on serum fibrinogen and renal tissue IFTA score

Journal of Diabetes Investigation, Volume 17, Issue 3, Page 448-459, March 2026.
ABSTRACT Objective To explore the association between serum fibrinogen (FIB) and clinicopathological features and renal prognosis in type 2 diabetic nephropathy (T2DN), and develop a web‐based dynamic model to predict renal progression. Methods This paper retrospectively enrolled 173 biopsy‐proven T2DN patients and stratified them by the optimal FIB ...
Lin Ning, Xiaohong Zhang, Yuan Fang, Mengjie Weng, Yongjie Zhuo, Jianxin Wan   +5 more
wiley   +1 more source

Improving nutritional assessment in GLP-1RA therapy: Beyond self-reports to equitable interventions. [PDF]

Obes Pillars
Aphale P, Shekhar H, Dokania S.
europepmc   +1 more source

7440 Both GLP-1RA and SGLT2i medications are associated with lower depression scores in veterans compared to metformin and insulin [PDF]

Shannen Nicole Dean Ubalde, Halle Cann, Layal Esper, Joseph Powell, Kristin Meyer, Sabyasachi Sen   +5 more
openalex   +1 more source

Effectiveness of GLP-1RA according to different type 2 diabetes phenotypes: A retrospective study. [PDF]

Diabetes Obes Metab
Caruso I, Giordano F, Matichecchia II, Di Gioia L, Di Molfetta S, Cignarelli A, Sorice GP, Natalicchio A, Laviola L, Giorgino F.   +9 more
europepmc   +1 more source

Time‐Related Biases in Observational Studies of GLP‐1 Agonists and Cancer Risk

Journal of Diabetes, Volume 18, Issue 3, March 2026.
Fei Lu
wiley   +1 more source

Racial and demographic disparities in glp-1ra use among breast cancer patients with Type 2 Diabetes. [PDF]

NPJ Breast Cancer
Hundal J, Ashruf OS, Li H, Basen-Engquist K, Kaelber DC, Sukumar JS.   +5 more
europepmc   +1 more source

Reply: Time‐Related Biases in Observational Studies of GLP‐1 Agonists and Cancer Risk

Journal of Diabetes, Volume 18, Issue 3, March 2026.
Zhiyuan Cheng, Jiesheng Lin, Dongfeng Gu, Fengchao Liang   +3 more
wiley   +1 more source